These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29926995)

  • 1. Prevalence of combined and noncombined dyslipidemia in an Iranian population.
    Darroudi S; Saberi-Karimian M; Tayefi M; Arekhi S; Motamedzadeh Torghabeh A; Seyedzadeh Sani SMR; Moohebati M; Heidari-Bakavoli A; Ebrahimi M; Azarpajouh MR; Safarian M; A Ferns G; Esmaeili H; Parizadeh MR; Mokhber N; Mahdizadeh A; Mahmoudi AA; Sahebkar AH; Ghayour-Mobarhan M
    J Clin Lab Anal; 2018 Oct; 32(8):e22579. PubMed ID: 29926995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of dyslipidemia among patients with diabetes mellitus in Jilin Province communities].
    He H; Li Y; Wang C; Tang Y; Yan Z; Lv L; Zhang H; Liu F; Gu Y; Meng T; Guan C; Yu Y; Liu Y
    Wei Sheng Yan Jiu; 2014 Sep; 43(5):743-8. PubMed ID: 25438527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).
    Opoku S; Gan Y; Fu W; Chen D; Addo-Yobo E; Trofimovitch D; Yue W; Yan F; Wang Z; Lu Z
    BMC Public Health; 2019 Nov; 19(1):1500. PubMed ID: 31711454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and cardiovascular disease risk among the MASHAD study population.
    Hedayatnia M; Asadi Z; Zare-Feyzabadi R; Yaghooti-Khorasani M; Ghazizadeh H; Ghaffarian-Zirak R; Nosrati-Tirkani A; Mohammadi-Bajgiran M; Rohban M; Sadabadi F; Rahimi HR; Ghalandari M; Ghaffari MS; Yousefi A; Pouresmaeili E; Besharatlou MR; Moohebati M; Ferns GA; Esmaily H; Ghayour-Mobarhan M
    Lipids Health Dis; 2020 Mar; 19(1):42. PubMed ID: 32178672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea.
    Achila OO; Fessahye N; Mengistu ST; Habtemikael NT; Werke WY; Zemichael FT; Leghese HN; Weldegegish TA; Tekeste TH; Garoy EY
    Sci Rep; 2022 Apr; 12(1):5567. PubMed ID: 35368036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
    Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
    Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population.
    Sharifi F; Mousavinasab SN; Soruri R; Saeini M; Dinmohammadi M
    Metab Syndr Relat Disord; 2008 Sep; 6(3):187-95. PubMed ID: 18774906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
    Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
    PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of dyslipidemia in the Iraqi adult population.
    Mula-Abed WA; Chilmeran SK
    Saudi Med J; 2007 Dec; 28(12):1868-74. PubMed ID: 18060219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study.
    Lin HQ; Wu JY; Chen ML; Chen FQ; Liao YJ; Wu YT; Guo ZJ
    Clin Interv Aging; 2019; 14():1119-1129. PubMed ID: 31354254
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.
    Tohidi M; Hatami M; Hadaegh F; Safarkhani M; Harati H; Azizi F
    Lipids Health Dis; 2010 Jan; 9():6. PubMed ID: 20096127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Associations between 4 lipid biomarkers and cardiometabolic multimorbidity development in middle aged and old adults in China].
    Jin YC; Cheng YY; Zhou YG; Zhang Y; Wang H; Xu XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Jul; 45(7):923-931. PubMed ID: 39004963
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014.
    Pedram P; Aref-Eshghi E; Mariathas HH; Hurley O; Godwin M; Duke P; Mahdavian M; Asghari S
    Lipids Health Dis; 2018 May; 17(1):99. PubMed ID: 29720176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.